Render Target: SSR
Render Timestamp: 2024-11-14T22:44:54.612Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-30 01:58:35.632
Product last modified at: 2024-11-08T16:30:09.012Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

ERAP1 (E6X1P) Rabbit mAb #99979

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 100
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    ERAP1 (E6X1P) Rabbit mAb recognizes endogenous levels of total ERAP1 protein. This antibody does not cross-react with ERAP2 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly840 of human ERAP1 protein.

    Background

    Endoplasmic reticulum aminopeptidase 1 (ERAP1) is an IFN-γ inducible peptidase that is inserted into the endoplasmic reticulum (ER) membrane as a type II transmembrane protein (1). Research studies have shown that ERAP1 influences the adaptive branch of the immune system by facilitating the maturation of peptide fragments that are loaded onto MHC class I alleles, which are then presented for recognition by T lymphocytes (2,3). Defects in ERAP1 are associated with human disease. Multiple single nucleotide polymorphisms have been identified within ERAP1, which alter the enzymatic activity of the protein product and, in conjunction with HLA-B27, confer susceptibility to ankylosing spondylitis, an inflammatory disease that affects joints (4,5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.